Scientists have developed a groundbreaking test that may predict bowel cancer risk with up to 90% accuracy. The research, ...
The groundbreaking study, funded by Cancer Research UK, has shown more than 90% accuracy in predicting bowel cancer risk in ...
Now, a study, funded by Cancer Research UK, has shown more than 90% accuracy in predicting bowel cancer risk in the next five ...
The study, funded by Cancer Research UK, could lead to a blood test which will inform doctors which inflammatory bowel ...
The method could be used to develop a blood test to identify inflammatory-bowel-disease patients most at risk.
Use precise geolocation data and actively scan device characteristics for identification. This is done to store and access ...
Doctors believe new test could lead to earlier diagnoses and more effective treatment for thousands of patients ...
We assign Teva a Morningstar Uncertainty Rating of High, which largely reflects our quantitative analysis of the firm, based on the return ranges used by our star rating system, as well as our ...
For decades, people in this area have been dealing with unusually high rates of serious health problems, such as multiple sclerosis, ulcerative colitis, Crohn’s disease, and various ...
Thousands of Scripps Health patients are still scrambling to find new medical care after Anthem and Scripps ceased their ...
Session: Poster and Exhibition Hall Reception Poster Title:PALI-2108, a Colon-Specific PDE4B Inhibitor Prodrug is Activated in the Colon and Reduces Ulcerative Colitis Symptoms in an Acute Colitis DSS ...